Summary of Significant Accounting Policies | Summary of Significant Accounting Policies a. Principles of Consolidation The consolidated financial statements include the accounts of the Company and all of its subsidiaries. Upon consolidation, all intercompany accounts and transactions are eliminated. Certain amounts reported in previous years have been reclassified to conform to the presentation for the fiscal year ended October 31, 2015 ( fiscal 2015 ). Such reclassified amounts were immaterial. The Company’s fiscal year is the 52 -week or 53 -week period ending on the Saturday closest to the last day in October. Fiscal 2015 , and the fiscal year ended November 1, 2014 (fiscal 2014) and the fiscal year ended November 2, 2013 (fiscal 2013) were 52 -week periods. On July 22, 2014, the Company completed its acquisition of Hittite Microwave Corporation (Hittite), a company that designed and developed high performance integrated circuits, modules, subsystems and instrumentation for radio frequency, microwave and millimeterwave applications. The total consideration paid to acquire Hittite was approximately $2.4 billion , financed through a combination of existing cash on hand and a 90-day term loan facility of $2.0 billion . The acquisition of Hittite is referred to as the Acquisition. The Consolidated Financial Statements include the financial results of Hittite prospectively from July 22, 2014, the closing date of the Acquisition. See Note 6, Acquisitions , of these notes to Consolidated Financial Statements for further discussion related to the Acquisition. b. Cash, Cash Equivalents and Short-term Investments Cash and cash equivalents are highly liquid investments with insignificant interest rate risk and maturities of ninety days or less at the time of acquisition. Cash, cash equivalents and short-term investments consist primarily of institutional money market funds, corporate obligations such as commercial paper and floating rate notes, bonds and bank time deposits. The Company classifies its investments in readily marketable debt and equity securities as “held-to-maturity,” “available-for-sale” or “trading” at the time of purchase. There were no transfers between investment classifications in any of the fiscal years presented. Held-to-maturity securities, which are carried at amortized cost, include only those securities the Company has the positive intent and ability to hold to maturity. Securities such as bank time deposits, which by their nature are typically held to maturity, are classified as such. The Company’s other readily marketable cash equivalents and short-term investments are classified as available-for-sale. Available-for-sale securities are carried at fair value with unrealized gains and losses, net of related tax, reported in accumulated other comprehensive (loss) income. Adjustments to the fair value of investments classified as available-for-sale are recorded as an increase or decrease in accumulated other comprehensive (loss) income, unless the adjustment is considered an other-than-temporary impairment, in which case the adjustment is recorded as a charge in the statement of income. The Company’s deferred compensation plan investments are classified as trading. See Note 7 for additional information on the Company’s deferred compensation plan investments. There were no cash equivalents or short-term investments classified as trading at October 31, 2015 or November 1, 2014 . The Company periodically evaluates its investments for impairment. There were no other-than-temporary impairments of short-term investments in any of the fiscal years presented. Realized gains or losses on investments are determined based on the specific identification basis and are recognized in nonoperating (income) expense. There were no material net realized gains or losses from the sales of available-for-sale investments during any of the fiscal periods presented. Gross unrealized gains and losses on available-for-sale securities classified as short-term investments at October 31, 2015 and November 1, 2014 were as follows: 2015 2014 Unrealized gains on securities classified as short-term investments $ 233 $ 541 Unrealized losses on securities classified as short-term investments (584 ) (407 ) Net unrealized losses on securities classified as short-term investments $ (351 ) $ 134 Unrealized gains and losses in fiscal years 2015 and 2014 relate to corporate obligations. As of October 31, 2015 , the Company held 76 investment securities, 23 of which were in an unrealized loss position with gross unrealized losses of $0.6 million and an aggregate fair value of $823.4 million . As of November 1, 2014 , the Company held 66 investment securities, 18 of which were in an unrealized loss position with gross unrealized losses of $0.4 million and an aggregate fair value of $694.7 million . These unrealized losses were primarily related to corporate obligations that earn lower interest rates than current market rates. None of these investments have been in a loss position for more than twelve months. As the Company does not intend to sell these investments and it is unlikely that the Company will be required to sell the investments before recovery of their amortized basis, which will be at maturity, the Company does not consider those investments to be other-than-temporarily impaired at October 31, 2015 and November 1, 2014 . The components of the Company’s cash and cash equivalents and short-term investments as of October 31, 2015 and November 1, 2014 were as follows: 2015 2014 Cash and cash equivalents: Cash $ 72,638 $ 117,337 Available-for-sale 807,935 447,968 Held-to-maturity 3,780 3,928 Total cash and cash equivalents $ 884,353 $ 569,233 Short-term investments: Available-for-sale $ 2,144,575 $ 2,297,235 Total short-term investments $ 2,144,575 $ 2,297,235 See Note 2j for additional information on the Company’s cash equivalents and short-term investments. c. Supplemental Cash Flow Statement Information 2015 2014 2013 Cash paid during the fiscal year for: Income taxes $ 142,931 $ 73,067 $ 36,863 Interest $ 25,625 $ 27,931 $ 29,354 d. Inventories Inventories are valued at the lower of cost (first-in, first-out method) or market. The valuation of inventory requires the Company to estimate obsolete or excess inventory as well as inventory that is not of saleable quality. The Company employs a variety of methodologies to determine the net realizable value of its inventory. While a portion of the calculation to record inventory at its net realizable value is based on the age of the inventory and lower of cost or market calculations, a key factor in estimating obsolete or excess inventory requires the Company to estimate the future demand for its products. If actual demand is less than the Company’s estimates, impairment charges, which are recorded to cost of sales, may need to be recorded in future periods. Inventory in excess of saleable amounts is not valued, and the remaining inventory is valued at the lower of cost or market. As of November 1, 2014, approximately $8.8 million of raw materials was classified as non-current and was presented within the consolidated balance sheet as other assets as the Company did not expect this inventory to be sold within one year. This inventory was purchased as part of a planned transition from a principal foundry supplier and was acquired by the Company through the Acquisition. The larger than normal purchase was made to maintain an adequate supply of the raw material for customers, which has a natural life of five to ten years. Inventories at October 31, 2015 and November 1, 2014 were as follows: 2015 2014 Raw materials $ 21,825 $ 47,267 Work in process 261,520 216,765 Finished goods 128,969 103,895 Total inventories $ 412,314 $ 367,927 Non-current inventories $ — $ 8,793 e. Property, Plant and Equipment Property, plant and equipment is recorded at cost less allowances for depreciation. The straight-line method of depreciation is used for all classes of assets for financial statement purposes while both straight-line and accelerated methods are used for income tax purposes. Leasehold improvements are amortized based upon the lesser of the term of the lease or the useful life of the asset. Repairs and maintenance charges are expensed as incurred. Depreciation and amortization are based on the following useful lives: Buildings Up to 25 years Machinery & equipment 3-8 years Office equipment 3-8 years Depreciation expense for property, plant and equipment was $130.1 million , $114.1 million and $110.2 million in fiscal 2015 , 2014 and 2013 , respectively. The Company reviews property, plant and equipment for impairment whenever events or changes in circumstances indicate that the carrying amount of assets may not be recoverable. Recoverability of these assets is determined by comparison of their carrying amount to the future undiscounted cash flows the assets are expected to generate over their remaining economic lives. If such assets are considered to be impaired, the impairment to be recognized in earnings equals the amount by which the carrying value of the assets exceeds their fair value determined by either a quoted market price, if any, or a value determined by utilizing a discounted cash flow technique. If such assets are not impaired, but their useful lives have decreased, the remaining net book value is amortized over the revised useful life. We have not recorded any material impairment charges related to our property, plant and equipment in fiscal 2015 , fiscal 2014 or fiscal 2013 . f. Goodwill and Intangible Assets Goodwill The Company evaluates goodwill for impairment annually as well as whenever events or changes in circumstances suggest that the carrying value of goodwill may not be recoverable. The Company tests goodwill for impairment at the reporting unit level (operating segment or one level below an operating segment) on an annual basis on the first day of the fourth quarter (on or about August 1) or more frequently if indicators of impairment exist. For the Company’s latest annual impairment assessment that occurred on August 2, 2015 , the Company identified its reporting units to be its six operating segments, , which meet the aggregation criteria for one reportable segment. The performance of the test involves a two-step process. The first step of the impairment test involves comparing the fair values of the applicable reporting units with their aggregate carrying values, including goodwill. The Company determines the fair value of its reporting units using the income approach methodology of valuation that includes the discounted cash flow method. If the carrying amount of a reporting unit exceeds the reporting unit’s fair value, the Company performs the second step of the goodwill impairment test to determine the amount of impairment loss. The second step of the goodwill impairment test involves comparing the implied fair value of the affected reporting unit’s goodwill with the carrying value of that reporting unit. There was no impairment of goodwill in any of the fiscal years presented. The Company’s next annual impairment assessment will be performed as of the first day of the fourth quarter of fiscal 2016 unless indicators arise that would require the Company to reevaluate at an earlier date. The following table presents the changes in goodwill during fiscal 2015 and fiscal 2014 : 2015 2014 Balance at beginning of year $ 1,642,438 $ 284,112 Acquisition of Hittite (Note 6) (1) (1,105 ) 1,357,077 Goodwill adjustment related to other acquisitions (2) 3,663 1,337 Foreign currency translation adjustment (8,470 ) (88 ) Balance at end of year $ 1,636,526 $ 1,642,438 (1) Amount in fiscal 2015 represents changes to goodwill as a result of finalizing the acquisition accounting related to the Acquisition. (2) Represents goodwill related to other acquisitions that were not material to the Company on either an individual or aggregate basis. Intangible Assets The Company reviews finite-lived intangible assets for impairment whenever events or changes in circumstances indicate that the carrying value of assets may not be recoverable. Recoverability of these assets is determined by comparison of their carrying value to future undiscounted cash flows the assets are expected to generate over their remaining economic lives. If such assets are considered to be impaired, the impairment to be recognized in earnings equals the amount by which the carrying value of the assets exceeds their fair value determined by either a quoted market price, if any, or a value determined by utilizing a discounted cash flow technique. As of October 31, 2015 and November 1, 2014 , the Company’s finite-lived intangible assets consisted of the following: October 31, 2015 November 1, 2014 Gross Carrying Amount Accumulated Amortization Gross Carrying Amount Accumulated Amortization Customer relationships $ 624,900 $ 88,913 $ 624,900 $ 19,473 Technology-based $ 16,200 $ 5,934 $ 16,200 $ 1,627 Backlog $ 25,500 $ 25,500 $ 25,500 $ 7,154 Total $ 666,600 $ 120,347 $ 666,600 $ 28,254 Amortization expense related to finite-lived intangible assets was $92.1 million , $27.9 million and $0.2 million in fiscal 2015 , 2014 and 2013 , respectively. The remaining amortization expense will be recognized over a weighted average life of approximately 3.9 years . The Company expects annual amortization expense for intangible assets as follows: Fiscal Year Amortization Expense 2016 $ 73,208 2017 $ 73,208 2018 $ 72,149 2019 $ 69,433 2020 $ 69,433 Indefinite-lived intangible assets are tested for impairment on an annual basis on the first day of the fourth quarter (on or about August 1) or more frequently if indicators of impairment exist. The impairment test involves a qualitative assessment on the indefinite-lived intangible assets to determine whether it is more likely-than not that the indefinite-lived intangible asset is impaired. If it is determined that the fair value of the indefinite-lived intangible asset is less than the carrying value, the Company would recognize into earnings the amount by which the carrying value of the assets exceeds the fair value. No impairment of intangible assets resulted from the impairment tests in any of the fiscal years presented. Definite-lived intangible assets, are amortized on a straight-line basis over their estimated useful lives or on an accelerated method of amortization that is expected to reflect the estimated pattern of economic use. IPR&D assets are considered indefinite-lived intangible assets until completion or abandonment of the associated R&D efforts. Upon completion of the projects, the IPR&D assets will be amortized over their estimated useful lives. Indefinite-lived intangible assets consisted of $37.3 million and $33.1 million of IPR&D as of October 31, 2015 and November 1, 2014 , respectively. g. Grant Accounting Certain of the Company’s foreign subsidiaries have received grants from governmental agencies. These grants include capital, employment and research and development grants. Capital grants for the acquisition of property and equipment are netted against the related capital expenditures and amortized as a credit to depreciation expense over the useful life of the related asset. Employment grants, which relate to employee hiring and training, and research and development grants are recognized in earnings in the period in which the related expenditures are incurred by the Company. h. Translation of Foreign Currencies The functional currency for the Company’s foreign sales and research and development operations is the applicable local currency. Gains and losses resulting from translation of these foreign currencies into U.S. dollars are recorded in accumulated other comprehensive (loss) income. Transaction gains and losses and re-measurement of foreign currency denominated assets and liabilities are included in income currently, including those at the Company’s principal foreign manufacturing operations where the functional currency is the U.S. dollar. Foreign currency transaction gains or losses included in other expenses, net, were not material in fiscal 2015 , 2014 or 2013 . i. Derivative Instruments and Hedging Agreements Foreign Exchange Exposure Management — The Company enters into forward foreign currency exchange contracts to offset certain operational and balance sheet exposures from the impact of changes in foreign currency exchange rates. Such exposures result from the portion of the Company’s operations, assets and liabilities that are denominated in currencies other than the U.S. dollar, primarily the Euro; other significant exposures include the Philippine Peso, the Japanese Yen and the British Pound. These foreign currency exchange contracts are entered into to support transactions made in the normal course of business, and accordingly, are not speculative in nature. The contracts are for periods consistent with the terms of the underlying transactions, generally one year or less . Hedges related to anticipated transactions are designated and documented at the inception of the respective hedges as cash flow hedges and are evaluated for effectiveness monthly. Derivative instruments are employed to eliminate or minimize certain foreign currency exposures that can be confidently identified and quantified. As the terms of the contract and the underlying transaction are matched at inception, forward contract effectiveness is calculated by comparing the change in fair value of the contract to the change in the forward value of the anticipated transaction, with the effective portion of the gain or loss on the derivative reported as a component of accumulated other comprehensive (loss) income (OCI) in shareholders’ equity and reclassified into earnings in the same period during which the hedged transaction affects earnings. Any residual change in fair value of the instruments, or ineffectiveness, is recognized immediately in other (income) expense. Additionally, the Company enters into forward foreign currency contracts that economically hedge the gains and losses generated by the re-measurement of certain recorded assets and liabilities in a non-functional currency. Changes in the fair value of these undesignated hedges are recognized in other (income) expense immediately as an offset to the changes in the fair value of the asset or liability being hedged. As of October 31, 2015 and November 1, 2014 , the total notional amount of these undesignated hedges was $57.9 million and $45.2 million , respectively. The fair value of these hedging instruments in the Company’s consolidated balance sheets as of October 31, 2015 and November 1, 2014 was immaterial . Interest Rate Exposure Management — The Company's current and future debt may be subject to interest rate risk. The Company utilizes interest rate derivatives to alter interest rate exposure in an attempt to reduce the effects of these changes. On October 28, 2014 , the Company entered into forward starting interest rate swap transactions to hedge its exposure to the variability in future cash flows due to changes in interest rates for debt issuances expected to occur in the future. Amounts reported in OCI related to these derivatives will be reclassified from OCI to earnings as interest expense is incurred on the forecasted hedged fixed-rate debt, adjusting interest expense to reflect the fixed-rate entered into by the forward starting swaps. These cash flow instruments hedge forecasted interest payments to be made through 2025. These forward starting swaps will be terminated on December 1, 2015 . As of October 31, 2015 and November 1, 2014 , the total notional value of these hedges was $500.0 million . The fair value of these hedges was $32.7 million as of October 31, 2015, included in accrued liabilities, and $1.7 million as of November 1, 2014, included in other assets, in the Company's consolidated balance sheet. On April 24, 2013 , the Company entered into a treasury rate lock agreement with Bank of America. This agreement allowed the Company to lock a 10-year US Treasury rate of 1.7845% through June 14, 2013 for its anticipated issuance of the $500.0 million aggregate principal amount of 2.875% senior unsecured notes due June 1, 2023 (2023 Notes). The Company designated this agreement as a cash flow hedge. On June 3, 2013 , the Company terminated the treasury rate lock simultaneously with the issuance of the 2023 Notes which resulted in a gain of approximately $11.0 million . This gain is being amortized into interest expense over the 10-year term of the 2023 Notes. During fiscal 2015 and fiscal 2014 approximately $1.1 million and $1.1 million , respectively, was amortized from OCI into interest expense and approximately $1.1 million will be amortized from OCI into interest expense within the next 12 months. On June 30, 2009 , the Company entered into interest rate swap transactions related to its outstanding $375.0 million aggregate principal amount of 5.0% senior unsecured notes due July 1, 2014 (the 2014 Notes) where the Company swapped the notional amount of its $375.0 million of fixed rate debt at 5.0% into floating interest rate debt through July 1, 2014 . The Company designated these swaps as fair value hedges. The fair value of the swaps at inception was zero and subsequent changes in the fair value of the interest rate swaps were reflected in the carrying value of the interest rate swaps on the balance sheet. The carrying value of the debt on the balance sheet was adjusted by an equal and offsetting amount. The amounts earned and owed under the swap agreements were accrued each period and were reported in interest expense. There was no ineffectiveness recognized in any of the periods presented. In the second quarter of fiscal 2012, the Company terminated the interest rate swap agreement. The Company received $19.8 million in cash proceeds from the swap termination, which included $1.3 million in accrued interest. The proceeds, net of interest received, are disclosed in cash flows from financing activities in the consolidated statements of cash flows. As a result of the termination, the carrying value of the 2014 Notes was adjusted for the change in the fair value of the interest component of the debt up to the date of the termination of the swap in an amount equal to the fair value of the swap, and was amortized into earnings as a reduction of interest expense over the remaining life of the debt. During fiscal 2013 and 2012, $4.6 million and $5.3 million , respectively, were amortized into earnings as a reduction of interest expense related to the swap termination. This amortization is reflected in the consolidated statements of cash flows within operating activities. During the third quarter of fiscal 2013, in conjunction with the redemption of the 2014 Notes, the Company recognized the remaining $8.6 million in unamortized proceeds received from the termination of the interest rate swap as other, net expense. The market risk associated with the Company’s derivative instruments results from currency exchange rate or interest rate movements that are expected to offset the market risk of the underlying transactions, assets and liabilities being hedged. The counterparties to the agreements relating to the Company’s derivative instruments consist of a number of major international financial institutions with high credit ratings. Based on the credit ratings of the Company’s counterparties as of October 31, 2015 , nonperformance is not perceived to be a material risk. Furthermore, none of the Company’s derivatives are subject to collateral or other security arrangements and none contain provisions that are dependent on the Company’s credit ratings from any credit rating agency. While the contract or notional amounts of derivative financial instruments provide one measure of the volume of these transactions, they do not represent the amount of the Company’s exposure to credit risk. The amounts potentially subject to credit risk (arising from the possible inability of counterparties to meet the terms of their contracts) are generally limited to the amounts, if any, by which the counterparties’ obligations under the contracts exceed the obligations of the Company to the counterparties. As a result of the above considerations, the Company does not consider the risk of counterparty default to be significant. The Company records the fair value of its derivative financial instruments in its consolidated financial statements in other current assets, other assets or accrued liabilities, depending on their net position, regardless of the purpose or intent for holding the derivative contract. Changes in the fair value of the derivative financial instruments are either recognized periodically in earnings or in shareholders’ equity as a component of OCI. Changes in the fair value of cash flow hedges are recorded in OCI and reclassified into earnings when the underlying contract matures. Changes in the fair values of derivatives not qualifying for hedge accounting or the ineffective portion of designated hedges are reported in earnings as they occur. The total notional amounts of forward foreign currency derivative instruments designated as hedging instruments of cash flow hedges denominated in Euros, British Pounds, Philippine Pesos and Japanese Yen as of October 31, 2015 and November 1, 2014 was $163.9 million and $183.5 million , respectively. The fair values of forward foreign currency derivative instruments designated as hedging instruments in the Company’s consolidated balance sheets as of October 31, 2015 and November 1, 2014 were as follows: Fair Value At Balance Sheet Location October 31, 2015 November 1, 2014 Forward foreign currency exchange contracts Accrued liabilities $ 3,091 $ 10,584 For information on the unrealized holding gains (losses) on derivatives included in and reclassified out of accumulated other comprehensive income into the consolidated statement of income related to forward foreign currency exchange contracts, see Note 2o, Accumulated Other Comprehensive (Loss) Income . The Company estimates that $1.8 million of forward foreign currency derivative instruments included in OCI will be reclassified into earnings within the next 12 months. There was no material ineffectiveness during the fiscal years ended October 31, 2015 and November 1, 2014 . All of the Company’s derivative financial instruments are eligible for netting arrangements that allow the Company and its counterparties to net settle amounts owed to each other. Derivative assets and liabilities that can be net settled under these arrangements have been presented in the Company's consolidated balance sheet on a net basis. As of October 31, 2015 and November 1, 2014 , none of the netting arrangements involved collateral. The following table presents the gross amounts of the Company's derivative assets and liabilities and the net amounts recorded in our consolidated balance sheet as of October 31, 2015 and November 1, 2014 : October 31, 2015 November 1, 2014 Gross amount of recognized liabilities $ (3,896 ) $ (10,736 ) Gross amounts of recognized assets offset in the consolidated balance sheet 813 643 Net liabilities presented in the consolidated balance sheet $ (3,083 ) $ (10,093 ) j. Fair Value The Company defines fair value as the price that would be received to sell an asset or be paid to transfer a liability in an orderly transaction between market participants at the measurement date. The Company applies the following fair value hierarchy, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). Level 1 — Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date. Level 2 — Level 2 inputs are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. If the asset or liability has a specified (contractual) term, a Level 2 input must be observable for substantially the full term of the asset or liability. Level 3 — Level 3 inputs are unobservable inputs for the asset or liability in which there is little, if any, market activity for the asset or liability at the measurement date. The tables below, set forth by level, presents the Company’s financial assets and liabilities, excluding accrued interest components, that were accounted for at fair value on a recurring basis as of October 31, 2015 and November 1, 2014 . The tables exclude cash on hand and assets and liabilities that are measured at historical cost or any basis other than fair value. As of October 31, 2015 and November 1, 2014 , the Company held $76.4 million and $121.3 million , respectively, of cash and held-to-maturity investments that were excluded from the tables below. October 31, 2015 Fair Value measurement at Reporting Date using: Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Other Unobservable Inputs (Level 3) Total Assets Cash equivalents: Available-for-sale: Institutional money market funds $ 198,853 $ — $ — $ 198,853 Corporate obligations (1) — 609,082 — 609,082 Short - term investments: Available-for-sale: Securities with one year or less to maturity: Corporate obligations (1) — 1,899,374 — 1,899,374 Floating rate notes, issued at par — 99,648 — 99,648 Floating rate notes (1) — 145,553 — 145,553 Other assets: Deferred compensation investments 24,124 — — 24,124 Total assets measured at fair value $ 222,977 $ 2,753,657 $ — $ 2,976,634 Liabilities Contingent consideration — — 2,843 2,843 Forward foreign currency exchange contracts (2) — 3,083 — 3,083 Interest rate swap agreements — 32,737 — 32,737 Total liabilities measured at fair value $ — $ 35,820 $ 2,843 $ 38,663 (1) The amortized cost of the Company’s investments classified as available-for-sale as of October 31, 2015 was $2.6 billion . (2) The Company has netting arrangements by counterparty with respect to derivative contracts. See Note 2i, Derivative Instruments and Hedging Agreements , for more information related to the Company's master netting arrangements. November 1, 2014 Fair Value measurement at Reporting Date using: Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Other Unobservable Inputs (Level 3) Total Assets Cash equivalents: Available-for-sale: Institutional money market funds $ 178,067 $ — $ — $ 178,067 Corporate obligations (1) — 269,901 — 269,901 Short - term investments: Available-for-sale: Securities with one year or less to maturity: Corporate obligations (1) — 2,122,120 — 2,122,120 Floating rate notes, issued at par — 85,061 — 85,061 Floating rate notes (1) — 50,010 — 50,010 Securities with greater than one year to maturity: Floating rate notes, issued at par — 40,044 — 40,044 Other assets: Deferred compensation investments 21,393 — — 21,393 Interest rate swap agreements — 1,723 — 1,723 Total assets measured at fair value $ 199,460 $ 2,568,859 $ — $ 2,768,319 Liabilities Contingent consideration — — 4,806 4,806 Forward foreign currency exchange contracts (2) — 10,093 — 10,093 Total liabilities measured at fair value $ — $ 10,093 $ 4,806 $ 14,899 (1) The amortized cost of the Company’s investments classified as available-for-sale as of November 1, 2014 was $2.3 billion . (2) The Company has master netting arrangements by counterparty with respect to derivative contracts. See Note 2i, Derivative Instruments and Hedging Agreements , for more information related to the Company's master netting arrangements. The following methods and assumptions were used by the Company in estimating its fair value disclosures for financial instruments: Cash equivalents and short-term investments — These investments are adjusted to fair value based on quoted market prices or are determined using a yield curve model based on current market rates. Deferred compensation plan investments — The fair value of these mutual fund, money market fund and equity investments are based on quoted market prices. Forward foreign currency exchange contracts — The estimated fair value of forward foreign currency exchange contracts, which includes derivatives that are accounted |